News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
25,973 Results
Type
Article (1309)
Company Profile (2)
Press Release (24662)
Section
Business (12982)
Career Advice (75)
Deals (1843)
Drug Delivery (3)
Drug Development (2106)
Employer Resources (2)
FDA (439)
Job Trends (655)
News (16746)
Policy (961)
Tag
Academia (35)
Alliances (904)
ALS (1)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (4)
Approvals (448)
Artificial intelligence (7)
Bankruptcy (7)
Best Places to Work (573)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (5)
Brain cancer (2)
Breast cancer (5)
Cancer (59)
Cardiovascular disease (6)
Career advice (53)
CAR-T (2)
Cell therapy (4)
Clinical research (1779)
Collaboration (13)
Compensation (6)
COVID-19 (100)
CRISPR (1)
C-suite (1)
Cystic fibrosis (2)
Data (85)
Depression (1)
Diabetes (13)
Diagnostics (292)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (11731)
Editorial (1)
Employer resources (2)
Events (2000)
Executive appointments (2)
FDA (508)
Funding (19)
Gene editing (2)
Gene therapy (4)
GLP-1 (18)
Government (161)
Guidances (49)
Healthcare (696)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (2)
Infectious disease (106)
Inflammatory bowel disease (5)
Interviews (10)
IPO (1363)
IRA (1)
Job creations (126)
Job search strategy (52)
Labor market (3)
Layoffs (21)
Leadership (1)
Legal (198)
Liver cancer (1)
Lung cancer (13)
Lymphoma (3)
Management (1)
Manufacturing (6)
MASH (3)
Medical device (585)
Medtech (585)
Mergers & acquisitions (497)
Metabolic disorders (26)
Multiple sclerosis (1)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (43)
NextGen: Class of 2025 (134)
Non-profit (52)
Now hiring (2)
Obesity (14)
Opinion (7)
Pain (8)
Pancreatic cancer (2)
Parkinson's disease (4)
Partnered (2)
Patents (1)
Patient recruitment (1)
People (778)
Pharmaceutical (1)
Phase I (402)
Phase II (690)
Phase III (753)
Pipeline (216)
Policy (1)
Postmarket research (103)
Preclinical (184)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (5)
Rare diseases (5)
Real estate (136)
Regulatory (651)
Reports (1)
Research institute (40)
Resumes & cover letters (14)
Rett syndrome (1)
RNA editing (1)
RSV (1)
Schizophrenia (3)
Series A (5)
Series B (2)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (93)
Supply chain (3)
The Weekly (1)
Vaccines (27)
Weight loss (10)
Women's health (2)
Worklife (1)
Date
Today (13)
Last 7 days (106)
Last 30 days (185)
Last 365 days (1429)
2025 (598)
2024 (1534)
2023 (1809)
2022 (2015)
2021 (2438)
2020 (1863)
2019 (1388)
2018 (1102)
2017 (831)
2016 (518)
2015 (816)
2014 (721)
2013 (302)
2012 (6446)
2011 (515)
2010 (533)
Location
Africa (22)
Alabama (1)
Arizona (4)
Asia (1832)
Australia (183)
California (247)
Canada (75)
China (16)
Colorado (12)
Connecticut (6)
Delaware (19)
Europe (3657)
Florida (41)
Georgia (12)
Idaho (2)
Illinois (21)
India (1)
Indiana (19)
Japan (10)
Kansas (2)
Kentucky (2)
Louisiana (4)
Maine (6)
Maryland (39)
Massachusetts (237)
Michigan (15)
Minnesota (19)
Missouri (2)
Montana (1)
Nevada (4)
New Hampshire (5)
New Jersey (87)
New York (79)
North Carolina (52)
Northern California (136)
Ohio (7)
Pennsylvania (73)
South America (38)
Southern California (87)
Tennessee (5)
Texas (37)
United States (1081)
Utah (11)
Virginia (4)
Washington D.C. (1)
Washington State (29)
25,973 Results for "135".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics
May 2, 2025
·
4 min read
Collaboration
AstraZeneca Sets Sights and $1.35B on Subcutaneous Cancer Drugs With Alteogen Alliance
Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology.
March 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Generic Pharmaceuticals Contract Manufacturing Market Size to Reach USD 135.36 Bn by 2034
February 14, 2025
·
1 min read
Press Releases
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
February 6, 2025
·
5 min read
Series B
Adcendo Rides ADC Wave With $135M Series B
Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.
November 25, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
BMS Taps Eisai’s Alzheimer’s Partner in Massive $1.35B Biobucks Deal
BioArctic received $100 million upfront with another $1.25 billion in potential milestone payments on the line for two pyroglutamate-amyloid-beta antibodies.
December 19, 2024
·
1 min read
·
Kate Goodwin
Press Releases
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
December 12, 2024
·
12 min read
Press Releases
Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
November 22, 2024
·
4 min read
Latigo Launches into Non-Opioid Pain Medicine Space with $135 Million Series A
Two weeks after Vertex’s Phase III data for VX-548 reenergized the field, Latigo Biotherapeutics announced $135 million in Series A funds to push its own NaV1.8 inhibitor into Phase II.
February 13, 2024
·
3 min read
·
Heather McKenzie
Press Releases
Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
November 25, 2024
·
3 min read
1 of 2,598
Next
